Search for: "Janssen Research " Results 1 - 20 of 209
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Oct 2019, 7:35 pm by Jean O'Grady
You will also have the opportunity to see a sophisticated new approach to AI enabled legal research. [read post]
10 Sep 2019, 5:00 am by Dani Alexis Ryskamp
Andrew Kolodny, the co-director of the Opioid Policy Research Collaborative at Brandeis University, stated that Johnson & Johnson had played a role in the creation of three different types of opioids: natural, semi-synthetic, and synthetic. [read post]
2 Sep 2019, 2:41 pm by Web Editor
Nonetheless, Johnson and Johnson, as well as its subsidiary, Janssen, were held to have understated the risk of addiction posed by the misuse of opioid painkillers Duragesic, Nucynta, Tylenol with Codeine, Tylox, Ultracet, and Ultram, ignoring decades of scientific research on the risk and instructing their sales representatives to concentrate their efforts upon high-opioid-prescribing physicians and to inform them that the risk is drastically lower if the opioids are prescribed… [read post]
12 Jun 2019, 6:02 am by Martin Husovec
Overview Chair Academic1 Academic2 Industry1 Industry2 Industry3 Panel 1 General issues Husovec Janssens Nordemann  Google  TBD GEMA Panel 2 Licensing modalities Kretschmer Quintais Moscon Twitch EVA SACEM Panel 3 Preventive obligations Kretschmer Frosio Peguera Siteground ACTE STM Panel 4 Over-blocking Husovec Kuczerawy Margoni Communia IFPI BEUC Panel 1: General Issues In the policy debate about the effects of Article 17 (ex-Article 13) of the… [read post]
29 May 2019, 6:57 am by Brian Lynch
Researchers combed through the FDA’s Adverse Event Reporting System and published case reports to compile their research. [read post]
28 Apr 2019, 7:45 am
In 1977 Edmund Kitch said that the grant of a patent could also have the purpose of encouraging further research on the patented subject matter, giving an analogy to a mining claim of staking out an area for further research. [read post]
4 Jan 2019, 5:00 am by D Daniel Sokol
Klaus Peter Gugler, Vienna University of Economics and Business; European Corporate Governance Institute (ECGI), Sven Heim, Centre for European Economic Research (ZEW), Maarten Janssen, University of Vienna - Faculty of Business, Economics, and Statistics, and Mario Liebensteiner, Vienna University of... [read post]
11 Dec 2018, 11:18 am by Howard Knopf
(https://www.blacklocks.ca)Blacklock’s will be back in the Federal Court tomorrow on December 12, 2018 at 90 Sparks St. in Ottawa at 9:30 AM with a “mega” motion record of almost 3,000 pages. [read post]
25 Sep 2018, 5:23 am by Dr. Begoña González Otero
The initial panel was chaired by Professor Marie-Christine Janssens, who set the scene for the discussion. [read post]
25 Jul 2018, 5:00 am by Laura Pennington
A plaintiff has alleged severe bleeding from Xarelto in a lawsuit against the manufacturer Janssen Research & Development and Johnson & Johnson. [read post]
15 Jun 2018, 5:00 am by Laura Pennington
More than 450,000 prescriptions for Invokana are filled every three months in the United States and the drug is marketed by Janssen Pharmaceuticals, a partner of Johnson and Johnson. [read post]
3 Apr 2018, 5:00 am by Christina Spicer
” The plaintiff claims that Xarelto was inadequately researched and over-promoted, leading to his severe injuries. [read post]
29 Mar 2018, 11:39 am by Dr. Shezad Malik
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
29 Mar 2018, 11:39 am by Dr. Shezad Malik
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
9 Mar 2018, 5:00 am by Christina Spicer
One study, says the review, had to be discarded because of research flaws. [read post]
5 Mar 2018, 4:25 pm by Law Offices of Jeffrey S. Glassman
This variation, researchers say, isn’t explained away by weather, years of exposure, changes in vehicle density or the economy. [read post]
5 Mar 2018, 4:25 pm by Law Offices of Jeffrey S. Glassman
This variation, researchers say, isn’t explained away by weather, years of exposure, changes in vehicle density or the economy. [read post]
5 Mar 2018, 5:00 am by Laura Pennington
The plaintiff, who is representing the deceased individual, alleges that Xarelto manufacturer Janssen Research and Development knew about severe bleeding risks but failed to warn the public and medical community about the dangers. [read post]
20 Feb 2018, 5:00 am by Christina Spicer
” Violations included discarding medical records, unauthorized unblinding, and even falsification of research records, according to the complaint. [read post]
31 Jan 2018, 10:31 am by Law Firm
Recent research also suggests that patients taking Invokana or Invokamet are twice as likely to undergo a lower limb amputation versus those with diabetes who are not taking these medications. [read post]